Swashthik Plascon Ltd

Swashthik Plascon Ltd

₹ 21.2 2.91%
27 May - close price
About

Incorporated in 2007, Swashthik Plascon Ltd manufactures PET preforms and PET bottles[1]

Key Points

Business Profile[1]
Swashthik Plascon Limited is a PET packaging manufacturer focused on PET bottles, PET preforms, jars, containers, and closures catering to pharmaceuticals, FMCG, liquor, household, industrial and beverage segments.

  • Market Cap 41.3 Cr.
  • Current Price 21.2
  • High / Low 48.5 / 15.8
  • Stock P/E 5.13
  • Book Value 48.0
  • Dividend Yield 0.00 %
  • ROCE 9.42 %
  • ROE 9.00 %
  • Face Value 10.0

Pros

  • Stock is trading at 0.44 times its book value

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has a low return on equity of 10.9% over last 3 years.
  • Company might be capitalizing the interest cost

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Half Yearly Results

Consolidated Figures in Rs. Crores / View Standalone

Sep 2023 Mar 2024 Sep 2024 Mar 2025 Sep 2025 Mar 2026
66 60 72 72 76 77
59 57 61 63 64 66
Operating Profit 7 3 11 10 12 11
OPM % 10% 5% 15% 13% 16% 14%
4 5 0 0 0 0
Interest 2 2 2 4 1 4
Depreciation 2 2 2 2 3 3
Profit before tax 7 4 6 3 7 4
Tax % 29% 36% 27% 19% 25% 28%
5 3 4 2 6 3
EPS in Rs 3.81 1.51 2.54 1.28 2.83 1.30
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Mar 2024 Mar 2025 Mar 2026
46 126 143 153
40 116 123 131
Operating Profit 6 10 20 23
OPM % 13% 8% 14% 15%
0 9 0 1
Interest 2 5 6 6
Depreciation 1 3 5 7
Profit before tax 3 11 9 11
Tax % 13% 32% 24% 26%
3 8 7 8
EPS in Rs 2.35 4.29 3.58 4.13
Dividend Payout % 0% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: 50%
TTM: 7%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: 39%
TTM: 16%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: -53%
Return on Equity
10 Years: %
5 Years: %
3 Years: 11%
Last Year: 9%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 13 18 19 19
Reserves 8 46 66 74
59 54 85 88
32 32 29 40
Total Liabilities 111 149 200 221
27 42 56 51
CWIP 0 0 0 30
Investments 1 1 1 1
82 107 143 139
Total Assets 111 149 200 221

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Mar 2024 Mar 2025 Mar 2026
4 -10 -19 34
-3 -18 -19 -32
-1 28 40 -4
Net Cash Flow -0 -0 2 -2
Free Cash Flow 1 -27 -39 1
CFO/OP 70% -80% -82% 155%

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 298 122 117 116
Inventory Days 436 215 246 297
Days Payable 212 91 72 101
Cash Conversion Cycle 523 245 292 312
Working Capital Days 149 202 248 165
ROCE % 16% 11% 9%

Insights

In beta
Mar 2023 Mar 2024 Mar 2025
Employee Headcount
Numbers

Log in to view insights

Please log in to see hidden values.

Login
Debtors Turnover Ratio
Times ・Standalone data
Number of Manufacturing Facilities
Units
Capacity Utilization
%
Manufacturing Shop Floor Area
Sq. Ft
Number of PET Product Variants/SKUs
Numbers
Pharma Segment Monthly Production Capacity
Tons (MT)
Total Monthly Production Capacity
Tons (MT)

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

2 Recently
Dec 2023Mar 2024Sep 2024Mar 2025Sep 2025Mar 2026
43.81% 43.81% 43.81% 39.53% 43.94% 44.46%
8.83% 1.67% 1.25% 0.00% 0.00% 0.00%
2.82% 0.00% 0.00% 0.70% 0.85% 0.00%
44.54% 54.52% 54.94% 59.79% 55.21% 55.54%
No. of Shareholders 1,2637868081,0151,0001,003

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents